guest ::
| Home > Publications database > EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. > print |
| Home > Publications database > EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. > print |
| 001 | 166311 | ||
| 005 | 20240229133519.0 | ||
| 024 | 7 | _ | |a 10.1038/s41571-020-00447-z |2 doi |
| 024 | 7 | _ | |a pmid:33293629 |2 pmid |
| 024 | 7 | _ | |a 1743-4254 |2 ISSN |
| 024 | 7 | _ | |a 1743-4262 |2 ISSN |
| 024 | 7 | _ | |a 1759-4774 |2 ISSN |
| 024 | 7 | _ | |a 1759-4782 |2 ISSN |
| 024 | 7 | _ | |a altmetric:95666753 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-02804 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Weller, Michael |b 0 |
| 245 | _ | _ | |a EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. |
| 260 | _ | _ | |a New York, NY |c 2021 |b Nature Publ. Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1620221564_814 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #LA:B320#2021 Mar;18(3):170-186 |
| 520 | _ | _ | |a In response to major changes in diagnostic algorithms and the publication of mature results from various large clinical trials, the European Association of Neuro-Oncology (EANO) recognized the need to provide updated guidelines for the diagnosis and management of adult patients with diffuse gliomas. Through these evidence-based guidelines, a task force of EANO provides recommendations for the diagnosis, treatment and follow-up of adult patients with diffuse gliomas. The diagnostic component is based on the 2016 update of the WHO Classification of Tumors of the Central Nervous System and the subsequent recommendations of the Consortium to Inform Molecular and Practical Approaches to CNS Tumour Taxonomy - Not Officially WHO (cIMPACT-NOW). With regard to therapy, we formulated recommendations based on the results from the latest practice-changing clinical trials and also provide guidance for neuropathological and neuroradiological assessment. In these guidelines, we define the role of the major treatment modalities of surgery, radiotherapy and systemic pharmacotherapy, covering current advances and cognizant that unnecessary interventions and expenses should be avoided. This document is intended to be a source of reference for professionals involved in the management of adult patients with diffuse gliomas, for patients and caregivers, and for health-care providers. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |x 0 |f POF IV |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a van den Bent, Martin |0 0000-0001-5710-5127 |b 1 |
| 700 | 1 | _ | |a Preusser, Matthias |0 0000-0003-3541-2315 |b 2 |
| 700 | 1 | _ | |a Le Rhun, Emilie |b 3 |
| 700 | 1 | _ | |a Tonn, Jörg C |b 4 |
| 700 | 1 | _ | |a Minniti, Giuseppe |0 0000-0003-1239-1603 |b 5 |
| 700 | 1 | _ | |a Bendszus, Martin |b 6 |
| 700 | 1 | _ | |a Balana, Carmen |0 0000-0003-0771-0390 |b 7 |
| 700 | 1 | _ | |a Chinot, Olivier |b 8 |
| 700 | 1 | _ | |a Dirven, Linda |b 9 |
| 700 | 1 | _ | |a French, Pim |0 0000-0002-0668-9529 |b 10 |
| 700 | 1 | _ | |a Hegi, Monika E |0 0000-0003-0855-6495 |b 11 |
| 700 | 1 | _ | |a Jakola, Asgeir S |0 0000-0002-2860-9331 |b 12 |
| 700 | 1 | _ | |a Platten, Michael |0 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |b 13 |u dkfz |
| 700 | 1 | _ | |a Roth, Patrick |b 14 |
| 700 | 1 | _ | |a Rudà, Roberta |b 15 |
| 700 | 1 | _ | |a Short, Susan |0 0000-0003-4423-7256 |b 16 |
| 700 | 1 | _ | |a Smits, Marion |0 0000-0001-5563-2871 |b 17 |
| 700 | 1 | _ | |a Taphoorn, Martin J B |b 18 |
| 700 | 1 | _ | |a von Deimling, Andreas |0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |b 19 |u dkfz |
| 700 | 1 | _ | |a Westphal, Manfred |b 20 |
| 700 | 1 | _ | |a Soffietti, Riccardo |0 0000-0002-9204-7038 |b 21 |
| 700 | 1 | _ | |a Reifenberger, Guido |0 P:(DE-HGF)0 |b 22 |
| 700 | 1 | _ | |a Wick, Wolfgang |0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |b 23 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s41571-020-00447-z |0 PERI:(DE-600)2491414-9 |n 3 |p 170-186 |t Nature reviews / Clinical oncology |v 18 |y 2021 |x 1759-4782 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:166311 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-09-04 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT REV CLIN ONCOL : 2018 |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-09-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-09-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-09-04 |
| 915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b NAT REV CLIN ONCOL : 2018 |d 2020-09-04 |
| 920 | 1 | _ | |0 I:(DE-He78)D170-20160331 |k D170 |l Neuroimmunologie und Hirntumorimmunologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B300-20160331 |k B300 |l KKE Neuropathologie |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)ED01-20160331 |k ED01 |l DKTK ED ES zentral |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)B320-20160331 |k B320 |l KKE Neuroonkologie |x 4 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D170-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B300-20160331 |
| 980 | _ | _ | |a I:(DE-He78)ED01-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B320-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|